chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 4/20/21 pt says she had swelling in left arm and 101 fever.  She started cramping in her right calf.  After a week of her leg hurting , on 4/27/21 she went to hospital.   She had blood test and doppler.  She was diagnosed w/ DVT of lower right extremity.  She was prescribed Xarelto and to FU w/ PCP in a week.
Patient received full series of both Moderna and Pfizer covid vaccines. He started at our clinic with his first dose of Moderna  (4/21/21), then used a local pharmacy to get the first dose of Pfizer (5/15/2021), he then returned to us for his second dose of Moderna (6/12/21) and then went back to the pharmacy to receive the second dose of Pfizer (7/10/21).
1st dose a year ago, forgot to get 2nd; This non-serious case was reported by a other health professional via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included shingrix (received first dose one year ago).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: 1st dose a year ago, forgot to get 2nd). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date:17-APR-2023 The reporter stated that the patient forgot to get second dose.  The reporter asked that how did she know if she has immunity or there was a lab test she can do since missed the window for second dose. The management requested for submission. Till the time of reporting, the patient did not receive the second dose of Shingrix, which led to Incomplete course of vaccination.
Fever; Joint pain, knee pain; Neck pain; This is a spontaneous report from a contactable physician, the patient. A 32-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 23Mar2021 at 15:00 (at the age of 32-year-old), as a single dose for COVID-19 immunisation. Medical history included asthma, ventricular septal defect and patient was suspected COVID-19 in Jan2021. Concomitant medications included BUPROPIN (150mg), vit C (MANUFACTURER UNKNOWN), folic acid (MANUFACTURER UNKNOWN), vit D (MANUFACTURER UNKNOWN) and zinc (MANUFACTURER UNKNOWN). Prior to the vaccination, the patient was diagnosed with COVID-19 in Jan2021. Since the vaccination, the patient had not been tested for COVID-19. On 24Mar2021 at 13:00 (after 24 hours of vaccination), the patient experienced fever of 38.9C, knee pain, joints pain and neck pain. The patient underwent body temperature and results was 38.9C. The patient received treatment for the adverse events with acetaminophen (MANUFACTURER UNKNOWN) and ibuprofen (MANUFACTURER UNKNOWN) for the reported events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, joints pain (knee pain) and neck pain were resolved on an unknown date in Mar2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Injection site pain, joint and muscle pain, fever, chills, feeling unwell  Side effects lasted 24 hours and receded afterwards
General poor feeling for 24-36 hours.  Slightly elevated body temperature.  One -2 degrees above norm.  Headache 24 hours after injection. Stayed in bed entire day after injection, chicken soup.  Woke up on the 5th feeling fine.  Body temp normal, good to go.
Pt received vaccine 2/24/06. Next day 2/25/2006 around 6:00 pm, she noticed erythematous rash over lateral right arm near inj site. Erythema continued spread to ant and med aspect of right arm with increased heat and tenderness. Pt treated with Keflex 500mg BID x 10d. Needs to recheck in 1 week.
one customer received the VAQTA vaccination 20 months ago and has not received the 2nd dose; no adverse event; This spontaneous report as received from a pharmacist refers to a 54-year-old male patient. No information on patient's pertinent medical history, drug reactions or allergies and concomitant medications was provided.  In approximately April 2019 (reported as 20 months ago), the patient was vaccinated with a dose of hepatitis a vaccine, inactivated (VAQTA) (lot #, expiration date, dose, route od administration and anatomical location were not reported) for prophylaxis. The patient did not received the second dose of the vaccine and the pharmacist asked about the administration cycle of hepatitis a vaccine, inactivated (VAQTA). No other adverse events were reported.
Client presented for 1st dose of Pfizer Covid Vaccine. Patient's history was reviewed indicating history of anaphylaxis to iodine. 30 minutes after vaccination, client reported she had numbness of her tongue (anterior 1/3), some numbness of her lower cheeks/jaw. No difficulty breathing. BP120/85; HR 80.  After a few minutes was reassessed and vitals were unchanged. Client felt anxious. No rashes, no breathing issues but continued anxiety and symptoms of numbness continued. 911 called. EMS assessed and vitals unchanged. Numbness lessened to just tip of tongue. Normal speech. EMS did not transport and father arrived to pick her up at 12:15 pm.
Narrative:  COVID infection following COVID vaccine series 07/19 Janssen, dose #1 10/05 pt cc: cough, fatigue, diarrhea, congestion, loss of taste or smell exposure: unknown 10/06 COVID swab, result: detected 10/06 SARS-COV-2 Variant Sequencing result: pending 11/06 CXR Impression: No acute abnormality. Remainder of findings as above.
No additional adverse events reported; a 9 month old patient was administered ROTATEQ; This spontaneous report was received from a physician assistant and refers to a 9 months old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On an unspecified date in March 2021 (reported as last week), the patient was vaccinated with a dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) 2 mL by mouth (lot # and expiration date were not provided) for prophylaxis (inappropriate age at vaccine administration). No adverse events were reported.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 71-year-old female patient who received SHINGRIX for prophylaxis. On 27th January 2019, the patient received the 2nd dose of SHINGRIX (intramuscular). On 27th January 2019, less than a day after receiving SHINGRIX, the patient experienced injection site pain. On 28th January 2019, the patient experienced neck pain, ear pain and toothache. On an unknown date, the outcome of the injection site pain was recovered/resolved and the outcome of the neck pain, ear pain and toothache were not recovered/not resolved. It was unknown if the reporter considered the injection site pain, neck pain, ear pain and toothache to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on left arm. One day after receiving vaccination, the patient experienced pain in neck, ear and teeth on her left side, the same side where the patient received SHINGRIX. The patient planned to follow-up with her physician on an unknown date. The reporter consented to follow up.
rash raised red;on trunk space, arms,T98.6;pruritic started 17APR99 improved by 22APR99;arthralgia hands, feet, knees started 19APR99 improved by 26APR99;tx w/OTC aveeno bath advil, DPH;
Stomach pain; This is a spontaneous report from a non-contactable consumer, the patient. A 20-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 07Apr2021(at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 09Apr2021 the patient experienced stomach pain. Therapeutic measures were not taken as a result of the reported adverse event. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event stomach pain was not recovered at the time of report.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Patient is fully vaccinated.  COVID + on 11/20/2021.  ED visit on 11/20/2021 . 82-year-old male, history of CAD CKD presented to the ED with generalized weakness over the past 6 days. General complaint is fagitue and cough. Patient denies any focal chest pain or abdominal pain. Does complain of decreased appetite and oral intake. Some mild shortness of breath. No vomiting or diarrhea.EKG reviewed and interpreted by myself, normal sinus rhythm, normal axis, biphasic T-wave in V2. Chest x-ray clear. Blood work noted for mild acidosis, suspect secondary to dehydration. Given IV fluid. Monitor in the ED for over 7 hours, no episodes of hypoxia. No increased work of breathing on reevaluation. Recommended outpatient follow-up with the antibody infusion clinic that his wife went to earlier this week. Told to return if symptoms acutely worsen. Told to return if oxygen level falls below 90%.
Patient states she has had a throbbing pain in arm since time of vaccine. Xray of the left humerus performed 11/19/15, result normal. Obtained CBC, results pending.
On 9/1/2022, the patient was given extra doses of Tdap and Hepatitis B. The immunization record was not updated, no immunization records or previous PCP records were scanned into media. The doctor ordered Tdap because there was no record of any being given in the patient's chart, and Hepatitis B because it appeared that the third dose of hepatitis B was given too early. However, in state record the Tdap series and Hepatitis B series had already been completed.
This spontaneous report was received from a physician, via company representatives and from a support services director, concerning to a patient of unknown age and gender. Information regarding medical history, concurrent conditions and concomitant medications was not provided. On 19-MAR-2015 the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 10 single Ds 0.5 ml Vls 10 SDV (lot number and expiration date: K007262 and 25-NOV-2015 respectively; route of administration was not provided). The vaccine had an excursion of 32 degrees Fahrenheit (0 degrees Celsius) (lowest recorded temperature) for 304 hours (sum of hours in excursion). The vaccine status was reported as "in excursion". The vaccine storage criteria and type were reported as "refrigerator (R)". No adverse events were reported. This is one of several reports received from the same reporter. Additional information has been requested.
Mild Vertigo; Ringing in ears; Sinus pressure; Headache; Mild headache; Little fever; First dose on 19-jan-2021 and second dose on 18-mar-2021; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Mild Vertigo), TINNITUS (Ringing in ears), PARANASAL SINUS DISCOMFORT (Sinus pressure), HEADACHE (Mild headache) and PYREXIA (Little fever) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0021321A and 13L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Bladder cancer.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 19-jan-2021 and second dose on 18-mar-2021). On 19-Mar-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEADACHE (Mild headache) and PYREXIA (Little fever). In April 2021, the patient experienced VERTIGO (Mild Vertigo), TINNITUS (Ringing in ears), PARANASAL SINUS DISCOMFORT (Sinus pressure) and HEADACHE (Headache). On 18-Mar-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (First dose on 19-jan-2021 and second dose on 18-mar-2021) had resolved. At the time of the report, VERTIGO (Mild Vertigo), TINNITUS (Ringing in ears), PARANASAL SINUS DISCOMFORT (Sinus pressure), HEADACHE (Mild headache), PYREXIA (Little fever) and HEADACHE (Headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Acoustic stimulation tests: negative (Negative) negative. On an unknown date, Computerised tomogram: negative (Negative) negative.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-385189 (Patient Link).
Information has been received from a physician concerning a 14 year old female patient who on approximately 19-JAN-2010 ("2 months ago") was vaccinated with the first dose of GARDASIL. On 19-MAR-2010, the patient was vaccinated IM with the second 0.5 ml dose of GARDASIL. In approximately January 2009 ("after the first dose"), the patient experienced missed two menstrual cycles. No lab diagnostics studies were performed. At the time of reporting, the patient was not recovered. The patient sought unspecified medical attention. Additional information has been requested.
1 day p/vax pt devel an inj site rxn characterized by an area of redness, swelling, pain & warmth measuring 2 inches in diameter;
Pt who in June and August of 1995 was vaccinated with a first and second dose of varicella virus vaccine live was tested and found to have a negative titer. On 09/08/1999 and 10/20/1999 the pt was vaccinated with a third and fourth dose of varicella virus vaccine live. The pt has not been re-titered as of yet.
Began with headache, progressed to dizziness, then felt hot, then felt like back of throat was swelling and had pressure in chest...then about 4PM progressed to shortness of breath, taken to Pediatric Urgent Care and given Prednisone. As of 6PM, breathing better and improved, As of 7AM still had headache but no respiratory symptoms.. Will be on prednisone for the next 4 days.
30 minutes after administration, my tongue and mouth became tingly and "fuzzy" causing me to have to continually clear my throat. My neck then began to itch and I broke out into a rash around the front of my neck.
Information has been received from a registered nurse concerning an approximately 3 year old male who on 17-Aug-2005 was vaccinated at another facility with a dose of MMR II. Concomitant therapy included HAVRIX. Post vaccination the child experienced a severe reaction, unknown what type of reaction, but serious enough that he was hospitalized at the time. After the episode occurred on 17-Aug-2005, child was discharged from the hospital with no complication. Additional information from the nurse indicated that the child experienced an anaphylactic reaction, respiratory difficulty, hypotension, abdominal pain, chest discomfort, shortness of breath, hives flushing and swelling around eyes. The patient was admitted to the hospital overnight. Diagnosis was an anaphylactic reaction. Subsequently, the patient had a similar experience following vaccination with Varivax (WAES# 0705USA01826). Additional information has been requested.
Patient received vaccine in left deltoid on 5/12/21.  On 5/14/21 started to have  left upper arm swelling, pain, warmth.  Had doppler done on 5/18/21that showed left brachial vein DVT.  Started on Eliquis immediately  At followup on 5/25/21, swelling reduced, pain and warmth resolved.
This spontaneous report as received from a registered nurse refers to a 4 month old patient. The patient's concurrent conditions, medical history and drug allergies were not reported. On 16-NOV-2016, the patient was vaccinated with improperly stored ROTATEQ, oral, (dose not reported) from lot # M031802 with expiry date: 09-NOV-2017 for prophylaxis. Concomitant medications were not reported. The vaccine was exposed to a temperature of 34.5 Fahrenheit for 100 minutes. Data logger was involved. There were no previous excursions. No adverse events were reported. Product quality complaint was not involved. This is one of the several reports received from the same reporter. Additional information is not expected as all correspondence has been received. Sender's Comments: US-009507513-1610USA008140: US-009507513-1610USA014705.
mom states pt would not walk p/vax because it hurt & ran a fever as high as 103 p/vax;9JAN97 denies any complaints and/or fever now;
Headache, body ache, chills, arm redness and tenderness, swollen lymph nodes and wheezing
On the morning of December 8, I experienced the same symptoms as when I took the J&J a few months ago. I had chills and couldn't get warm. I was at home and put on a hoodie, coat and gloves and still couldn't get warm. My right arm was very sore. I wanted to lay down and go to bed but I'm working from home, so it made for a rough day. I was in bed early. The next day the chills were gone but I had a slightly sore throat and cough. I felt as if I was coming down with a cold. That lasted for the rest of the day. By Friday, December 10, I had no symptoms at all.
Husband reports that pt was taken to local hospital by EMS & transferred to facility following a seizure at home around 22:00.  She has  had seizure type activity prior to this event she was admitted to medical center and treated (he didn't go into detail).  She was released and is home she is still having issues with severe weakness and fatigue and sleeping most of the time.  The events were reported to our hospital on 4/14/21.
Tested positive for Covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Tested positive for Covid) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical reported history).    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Tested positive for Covid). At the time of the report, COVID-19 (Tested positive for Covid) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Received varicella vaccine 11/8 3d had fever 1-2 wks later eruption of vesicle sl patch of redness poss shingles. She previously has had other vaccines without side effects/similar occurrence.
Expired dose of Heplisav-B; Initial Report Received on 23-Apr-2021  A vaccine coordinator reported that a 24 year-old male (race and ethnicity not provided) received an expired dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization.  No relevant medical history was reported.    No relevant concomitant medications were reported.    On 20-Apr-2021, the patient received a dose of HEPLISAV-B (Lot # 933094, expiration date 17-Apr-2021, serial number 304810276431 NDC # 43528-003-05) , in the right deltoid at a student health center.   At the time of report, no adverse events were reported.  No additional information was reported.   Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.
REDNESS/RAISED WARMTH 5 CM X 4 CM OF R ARM PAIN WITH MOVEMENT OF ARM. TX: COOL COMPRESSES AND CONTINUE AMOXIL PRESCRIBED ON 12/12/06 FOR OME
Symptoms stated within 24 hrs. of the injection. Symptoms include fatigue, weakness in right arm, mild fever, swollen lymph nodes involving the right axilla, supraclavicular notch and neck
Information has been received from a healthcare worker referring to unspecified patients of unknown age and gender. The unspecified patients were administered ROTATEQ (lot# K024700, expiration date 30-JUL-2016) (oral, dose and frequency not reported), which were exposed to temperatures outside of the recommended range since 05-NOV-2015. No adverse experience had been reported. This is one of several reports received from the same reporter. Additional information has been requested.
Hospital admission with covid 19 nasal drainage only, for daily observation due to need for daily observations, caregiver also with COVID 19
Vaccines were administered following a temperature excursion; No adverse event; This spontaneous report was received from a vaccine coordinator/administrator and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant medications was provided.  On an unknown date, the patient was vaccinated with improperly stored dose (product storage error) of haemophilus b conjugate vaccine (meningococcal protein conjugate)(LIQUID PEDVAXHIB) lot # T030707, expiration date: 14-APR-2023 (dose number, dose and route of administration were not reported) for prophylaxis.  It was reported that the vaccine was stored in the temperature of 48 Fahrenheit (F) for a time frame of 1 hour and 2 minutes without a previous temperature excursion. There were no adverse reactions (no adverse event).  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2110USA003600: US-009507513-2110USA003602: US-009507513-2110USA003603: US-009507513-2110USA003604: US-009507513-2110USA003605: US-009507513-2110USA003599: US-009507513-2109USA001290:
Headache following day, stopped with medication. Swollen and sore left armpit, ongoing
On Thursday, I noticed bilateral redness on my arms on the inner aspect of elbow. I thought it was chapped skin or from a too-hot shower.  On Friday afternoon, the redness was more pronounced and it had spread to the bicep/ tricep area. It looked like a viral rash and the reddest part was still the inner aspect of the elbow. There was no itching or pain.  I treated it with Aquaphor, steroid cream, and Benadryl at night.  It was mostly resolved on Sunday although the skin is still very rough.
Satellite lesions noted on day 9,10, and 11. Draining pus and clear. Myalgia, headache, flashback pain, axillary lymphadenopathy. These symptoms were reported by Dr., herself who filled in the VAERS and had it faxed into the State. Clarification of information for all blanks obtained on 4-21-2003.
Chills, headache, and tempature got as high as 101.7, which i usually run 98.7.